Ada Patient Finder -- Daily Briefing

Pipeline Snapshot

€97,534,437

Total Pipeline (Unweighted)

€7,946,653

Weighted Pipeline

135

Open Opps

€0

Closing This Quarter

3

Calls Yesterday

4.0

7-Day Avg Calls

53

Stale Deals

Stage Moves (Last 24h)

Dronline Advanced

Moved from Contracting | 80% to Discovery | 10% (Adel Baluch)
€300,000

Pipeline Changes

No pipeline changes

Stale Deals (14+ Days in Stage)

Crohns Colitis Foundation 369d No Contact

Jacob Plummer | Qualification | 5% | €423,775

Ontario Enhancements - Suicide Pop Up - Delivery 258d No Contact

Simon Wolpert | Qualification | 5% | €247,943

Ontario SOW9 - Health Care Connect (Primary Care Attachment) - Planning Only 199d No Contact

Simon Wolpert | Proposal | 30% | €30,992

Astrazeneca - Wainua 152d No Contact

Usaid Cheema | Qualification | 5% | €500,000

Walgreens/Boots 148d No Contact

Randal Whitmore | Qualification | 5% | €423,775

Patient Finder for Temple Health 147d No Contact

Randal Whitmore | Qualification | 5% | €423,775

Relevate health 145d No Contact

Jacob Plummer | Qualification | 5% | €84,755

Health 811 SOW9 - HCC + Survey Planning + Delivery 140d No Contact

Simon Wolpert | Proposal | 30% | €92,978

DKV Seguros 134d No Contact

Johannes Vonhuelsen | Discovery | 10% | €486,000

GSK - Shingrix 118d No Contact

Usaid Cheema | Qualification | 5% | €423,775

+43 more stale deals

No Decision Maker Engaged

All tracked deals have decision maker contact

Flagged Calls (< 3.0)

No flagged calls

Calls Yesterday (3)

Weekly ELT meeting 52m

Participants:
Next steps: It's almost like negligent if we don't use the best tools at our disposal, I guess

Jefferson Pitch Optional Pre-Sync Hold 22m

Participants:

Jefferson Presentation & Debrief 53m

Participants:

Top Deals by Value

GNAL
Qualification | 5%

€20,500,000

Biogen | Friedreichs Ataxia | Global - Phase 2
Qualification | 5%

€6,000,000

Blue Shield of California
Proposal | 30%

€5,509,081

Alberta Health Services - Patient Portal (via Orion & Telus/IBM)
Qualification | 5%

€4,803,902

Resmed Phase 2
Qualification | 5%

€2,542,653

SANOFI | Diabetes | TZIELD | US - Phase 2
Discovery | 10%

€2,542,653

Biogen Germany FA extension
Discovery | 10%

€2,100,000

Blue Cross Blue Shield Arizona
Qualification | 5%

€1,440,836

Meetings Today

10:00 AM -- shireen.saxena@ada.com

Daniel/Shireen - outreach and tool set up

11:30 AM -- jacob.plummer@ada.com

Daniel/Jake Sync

1:00 PM

Text/call CvB - follow up with NVS, Recordati

2:00 PM

Strategy Block